David Dodd is the Chairman, President, and CEO of GeoVax Labs, Inc., a clinical-stage biotechnology company developing vaccines and immunotherapies.
David Dodd is the Chairman, President, and CEO of GeoVax Labs, Inc., a clinical-stage biotechnology company developing vaccines and immunotherapies. He leads the company's Phase 1/2 clinical trial for Gedeptin, an oncolytic solid tumor gene-directed therapy.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide